Ligand validation:4XXJ

LFA: EICOSANE

LFA is a Ligand Of Interest in 4XXJ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
4XXJ_LFA_A_313	31%	84%	0.14	0.897	0.24	0.52	-	-	1	50%	1
4XXJ_LFA_A_309	28%	90%	0.11	0.888	0.27	0.34	-	-	0	30%	1
4XXJ_LFA_B_302	26%	89%	0.162	0.927	0.28	0.35	-	-	0	30%	1
4XXJ_LFA_C_305	25%	89%	0.127	0.878	0.24	0.4	-	-	0	35%	1
4XXJ_LFA_C_304	22%	84%	0.117	0.819	0.25	0.51	-	-	0	50%	1
4XXJ_LFA_B_305	19%	89%	0.142	0.862	0.26	0.39	-	-	0	30%	1
4XXJ_LFA_A_306	18%	87%	0.15	0.849	0.24	0.45	-	-	0	35%	1
4XXJ_LFA_C_303	17%	81%	0.231	0.888	0.18	0.62	-	-	0	55%	1
4XXJ_LFA_B_301	16%	87%	0.164	0.848	0.26	0.42	-	-	0	35%	1
4XXJ_LFA_B_304	16%	89%	0.14	0.832	0.25	0.38	-	-	0	30%	1
4XXJ_LFA_A_304	16%	85%	0.204	0.859	0.24	0.5	-	-	0	50%	1
4XXJ_LFA_A_303	14%	83%	0.259	0.893	0.24	0.54	-	-	3	55%	1
4XXJ_LFA_A_302	14%	86%	0.223	0.906	0.3	0.41	-	-	0	25%	1
4XXJ_LFA_C_312	13%	88%	0.167	0.838	0.28	0.39	-	-	1	25%	1
4XXJ_LFA_A_301	13%	88%	0.188	0.84	0.24	0.43	-	-	0	35%	1
4XXJ_LFA_C_309	12%	89%	0.204	0.857	0.25	0.39	-	-	0	30%	1
4XXJ_LFA_B_306	12%	90%	0.173	0.822	0.23	0.38	-	-	0	30%	1
4XXJ_LFA_B_307	11%	83%	0.158	0.761	0.26	0.51	-	-	2	50%	1
4XXJ_LFA_A_305	10%	87%	0.147	0.771	0.26	0.44	-	-	0	35%	1
4XXJ_LFA_C_302	10%	87%	0.218	0.838	0.28	0.4	-	-	0	35%	1
4XXJ_LFA_A_308	9%	87%	0.167	0.769	0.25	0.44	-	-	0	35%	1
4XXJ_LFA_B_303	9%	86%	0.167	0.765	0.26	0.45	-	-	0	35%	1
4XXJ_LFA_C_307	8%	90%	0.208	0.803	0.26	0.36	-	-	0	30%	1
4XXJ_LFA_A_312	8%	85%	0.201	0.775	0.29	0.45	-	-	1	40%	1
4XXJ_LFA_A_310	7%	90%	0.19	0.76	0.27	0.34	-	-	0	30%	1
4XXJ_LFA_C_306	6%	90%	0.172	0.734	0.25	0.34	-	-	0	30%	1
4XXJ_LFA_C_311	5%	84%	0.176	0.645	0.28	0.48	-	-	1	70%	1
4XXJ_LFA_A_311	5%	82%	0.209	0.702	0.26	0.53	-	-	1	50%	1
4XXJ_LFA_A_307	5%	86%	0.194	0.707	0.26	0.45	-	-	0	35%	1
4XXJ_LFA_C_308	4%	90%	0.219	0.707	0.28	0.34	-	-	0	30%	1
4XXJ_LFA_B_308	2%	84%	0.211	0.615	0.27	0.49	-	-	1	40%	1
4XXJ_LFA_C_301	2%	87%	0.277	0.681	0.29	0.4	-	-	0	35%	1
4XXJ_LFA_C_310	1%	90%	0.21	0.515	0.28	0.33	-	-	0	30%	1
7Z0D_LFA_A_801	47%	94%	0.095	0.949	0.26	0.2	-	-	0	35%	1
7Z0A_LFA_A_801	46%	76%	0.095	0.945	0.3	0.65	-	-	1	35%	1
7Z09_LFA_A_801	40%	76%	0.087	0.914	0.37	0.58	-	-	1	35%	1
7Z0C_LFA_A_807	40%	72%	0.101	0.898	0.28	0.78	-	-	1	50%	1
7Q38_LFA_A_302	37%	98%	0.158	0.872	0.19	0.11	-	-	1	90%	0.5
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	60%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	75%	1
8QLF_LFA_A_408	56%	100%	0.083	0.933	0.1	0.06	-	-	1	55%	1
8R98_LFA_A_401	55%	100%	0.089	0.937	0.09	0.08	-	-	0	55%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

4XXJ

LFA: EICOSANE

LFA is a Ligand Of Interest in 4XXJ designated by the RCSB